United States· US:42507-710_29b81e08-390c-4662-aee8-3ce975597d3c
allergy relief nasal
A fluticasone product containing fluticasone propionate, registered in United States by HyVee Inc. The same ATC class is registered in 10 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Fluticasone is registered in 10 of 19 countries.
Countries holding a registration under ATC D07AC17 (fluticasone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Fluticasone · ATC D07AC17
10 / 19 countries
- Belgiumprice
- Finlandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Fluticasone propionate
- Manufacturer
- HyVee Inc
- Country
- United States (US)
- ATC code
- D07AC17
- ATC class
- Fluticasone
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc1142507710102 BOTTLE, SPRAY in 1 CARTON (42507-710-10) / 144 SPRAY, METERED in 1 BOTTLE, SPRAY (42507-710-00)
Regulatory notes
Interactions
56 interactions on record for fluticasone.
Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fluticasone · interactions on record
56 records
- 1 moderate
- 55 minor
Most severe, free to view
- EchinaceaD03AH02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fluticasone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- Canada24HR NASAL ALLERGY RELIEFAPOTEX INC
- United KingdomAvamys 27.5micrograms/dose nasal sprayMawdsley-Brooks & Company Ltd
- FinlandAvamysParanova Oy
- SpainAVAMYS 27,5 mcg/PULVERIZACION PARA SUSPENSION NASALGlaxo Group Limited
- BelgiumAerivio Spiromax 50 µg - 500 µgTeva
- NetherlandsCortifil 0,5 mg/g crèmeLaboratorios SALVAT, S.A.
- Japanフルチカゾンフランカルボン酸エステルグラクソ・スミスクライン
- CzechiaAVAMYSGlaxoSmithKline Trading Services Limited, Dublin
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Flixonase Aquosum, Flixotide Diskus Forte
- Belgium · Flixonase Aqua, Flixotide
- Bulgaria · Аркуист, Фликсоназе
- Cyprus · Cutivate, Flixonase Aqueous
- Czechia · Flixotide Diskus, Flixotide Inhaler N
- Germany · Flutica, Fluticason Cipla
- Denmark · Flixotide, Flurhin
- Estonia · Cutivate Cream, Flixonase
- Spain · Avancort, Flixonase
- Finland · Flixonase, Flixotide Diskus
- France · Fixorinox, Flixonase
- United Kingdom (Northern Ireland) · Aeronate, Boots Allergy Relief
- Greece · Alerxem, Bocacort-S
- Croatia · Flixonase, Flixotide Inhaler
- Hungary · Cutivate, Flixonase
- Ireland · Arquist, Flixonase Allergy Relief
- Iceland · Avamys, Flixotide
- Italy · Aktanos, Deflut
- Liechtenstein · Avamys
- Lithuania · Cutivate, Flixotide
- Luxembourg · Flixonase Aqua, Flixotide
- Latvia · Flixonase, Flixotide
- Malta · Cutivate, Flihaler
- Netherlands · Cortifil, Cutivate
- Norway · Avamys, Flurhin
- Poland · Cutivate, Fanipos
- Portugal · Brisovent Diskus, Brisovent Inalador
- Romania · Arquist, Cutivate
- Sweden · Arquist, Fluticasone Cipla
- Slovenia · Flixonase, Flixotide
- Slovakia · Flixonase Aqueous, Flixotide Diskus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9a931ad4-af88-427d-81c8-16e121e6d48e GET /v1/drugs/9a931ad4-af88-427d-81c8-16e121e6d48e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "O2GMZ0LF5W",
"rxcui": "50121",
"inchikey": "WMWTYOKRWGGJOA-CENSZEJFSA-N",
"display_name": "FLUTICASONE PROPIONATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "NASAL",
"spl_meta": {
"934c7b91-3cba-47f0-8efa-77216f3f15c4": {
"match": "brand_token",
"title": "ALLERGY RELIEF CHILDRENS (DIPHENHYDRAMINE HCL) TABLET, CHEWABLE [AMERISOURCE BERGEN]",
"spl_version": "14",
"published_date": "2026-06-01"
}
},
"productid": "42507-710_29b81e08-390c-4662-aee8-3ce975597d3c",
"productndc": "42507-710",
"dosage_form": "SPRAY, METERED",
"orange_book": {
"appl_no": "207957",
"products": [
{
"rs": true,
"rld": false,
"te_code": null,
"strength": "0.05MG/SPRAY",
"product_no": "001",
"approval_date": "May 26, 2016"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN OTC DRUG",
"substance_name": "FLUTICASONE PROPIONATE",
"shortage_reason": "Fluticasone Propionate; Salmeterol Xinafoate Powder",
"shortage_status": "current",
"proprietary_name": "allergy relief nasal",
"active_ingred_unit": "ug/1",
"application_number": "ANDA207957",
"marketing_category": "ANDA",
"nonproprietary_name": "Fluticasone propionate",
"start_marketing_date": "20260128",
"active_numerator_strength": "50"
}See everything about fluticasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.